Hepatitis C - Parenteral drug use Factor

Last reviewed for CCPS 30 April 1997.

Investigative Documents

Claimant Report - Parenteral Drug Use - Hepatitis C [CR9042]

Preliminary questions [10237]

10302

10305 — the veteran has established the causal connection between the parenteral drug use and VEA service for the clinical onset of hepatitis C.

10318 — the veteran has established the causal connection between the parenteral drug use and operational service for the clinical onset of hepatitis C.

or

10307 — the veteran has established the causal connection between the parenteral drug use and eligible service for the clinical onset of hepatitis C.

Clinical onset and operational service [10318]

10314 — the identified illness or injury which caused the parenteral drug use, in the course of which the veteran shared needles more than 2 weeks before the clinical onset of hepatitis C, is causally related to operational service.

Clinical onset and eligible service [10307]

10315 — the identified illness or injury which caused the parenteral drug use, in the course of which the veteran shared needles more than 2 weeks before the clinical onset of hepatitis C, is causally related to eligible service.